In our recent note (‘Born in the USA', 25 June) we discussed in some detail Allergy Therapeutics' differentiated technology platform as a key element of the group's competitive positioning. This morning, the group has announced the publication of a key paper and featured article in the World Allergy Journal, about proteomics in the field of allergy. We regard the advancement of research at the cutting edge of the field represents a continued recognition of its importance on the part of
